DAWN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $5,407,223.64

Day One Biopharmaceuticals Insider Trading History Chart

Day One Biopharmaceuticals Share Price & Price History

^$14.32

▼ -0.53 (-3.57%)

As of 11/14/2024 01:00 AM ET

Days: 30 | 90 | 365

The #1 Crypto for AI

From Weiss Ratings | Ad

We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”

Learn more about it by watching THIS NOW.

Day One Biopharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/11/2024	Samuel C. Blackman	Insider	Sell	10,000	$16.10	$161,000.00	1,057,535
11/7/2024	Samuel C. Blackman	Insider	Sell	11,245	$16.03	$180,257.35	1,085,790
10/31/2024	Samuel C. Blackman	Insider	Sell	500	$16.02	$8,010.00	1,097,035
9/10/2024	Samuel C. Blackman	Insider	Sell	30,000	$14.22	$426,600.00	1,097,535
8/16/2024	Adam Dubow	General Counsel	Sell	3,202	$14.00	$44,828.00	26,928
8/16/2024	Charles N York II	CFO	Sell	2,633	$14.00	$36,862.00	232,485
8/16/2024	Jeremy Bender	CEO	Sell	10,681	$14.00	$149,534.00	98,932
8/16/2024	Samuel C. Blackman	Insider	Sell	2,232	$14.00	$31,248.00	1,127,535
7/16/2024	Samuel C. Blackman	Insider	Sell	20,000	$16.01	$320,200.00	1,121,081
6/21/2024	Saira Ramasastry	Director	Sell	10,000	$13.19	$131,900.00	40,485
5/16/2024	Adam Dubow	General Counsel	Sell	3,253	$16.08	$52,308.24	21,731
5/16/2024	Charles N York II	CFO	Sell	2,675	$16.08	$43,014.00	224,868
5/16/2024	Jeremy Bender	CEO	Sell	7,873	$16.08	$126,597.84	654,728
5/16/2024	Samuel C. Blackman	Insider	Sell	2,267	$16.08	$36,453.36	1,171,081
5/10/2024	Samuel C. Blackman	Insider	Sell	10,000	$16.37	$163,700.00	1,164,662
5/3/2024	Charles N York II	CFO	Sell	8,078	$17.85	$144,192.30	217,293
5/3/2024	Jeremy Bender	CEO	Sell	9,154	$17.85	$163,398.90	642,602
5/1/2024	Charles N York II	CFO	Sell	52,183	$17.89	$933,553.87	225,571
5/1/2024	Jeremy Bender	CEO	Sell	70,051	$17.88	$1,252,511.88	651,762
4/18/2024	Samuel C. Blackman	Insider	Sell	10,000	$16.02	$160,200.00	1,174,662
3/25/2024	Samuel C. Blackman	Insider	Sell	10,000	$16.01	$160,100.00	1,184,662
2/27/2024	Samuel C. Blackman	Insider	Sell	20,000	$16.11	$322,200.00	1,224,662
2/16/2024	Adam Dubow	General Counsel	Sell	3,242	$15.25	$49,440.50	16,585
2/16/2024	Charles N York II	CFO	Sell	2,666	$15.25	$40,656.50	277,754
2/16/2024	Jeremy Bender	CEO	Sell	7,615	$15.25	$116,128.75	721,813
2/16/2024	Samuel C. Blackman	Insider	Sell	2,258	$15.25	$34,434.50	1,244,662
11/16/2023	Adam Dubow	General Counsel	Sell	5,313	$11.69	$62,108.97	11,428
11/16/2023	Charles N York II	CFO	Sell	956	$11.69	$11,175.64	270,170
11/16/2023	Jeremy Bender	CEO	Sell	3,107	$11.69	$36,320.83	709,429
11/16/2023	Samuel C. Blackman	Insider	Sell	709	$11.69	$8,288.21	1,238,234
10/19/2023	Ai Day1 Llc	Major Shareholder	Buy	384,400	$10.06	$3,867,064.00	12,817,935
8/17/2023	Charles N York II	CFO	Sell	922	$13.86	$12,778.92	267,501
8/17/2023	Jeremy Bender	CEO	Sell	2,996	$13.86	$41,524.56	704,224
8/17/2023	Samuel C. Blackman	Insider	Sell	668	$13.86	$9,258.48	1,236,319
6/9/2023	Ai Day1 Llc	Major Shareholder	Buy	769,230	$13.00	$9,999,990.00	11,453,868
6/5/2023	Samuel C. Blackman	Insider	Sell	1,229	$16.00	$19,664.00	1,234,363
5/16/2023	Charles N York II	CFO	Sell	955	$13.12	$12,529.60	264,798
5/16/2023	Jeremy Bender	CEO	Sell	3,104	$13.12	$40,724.48	1,179,484
5/16/2023	Samuel C. Blackman	Insider	Sell	692	$13.12	$9,079.04	1,235,592
3/10/2023	Samuel C. Blackman	Insider	Sell	10,000	$18.05	$180,500.00	1,233,660
3/7/2023	Jeremy Bender	CEO	Sell	12,500	$20.01	$250,125.00	1,174,276
2/16/2023	Charles N York II	CFO	Sell	930	$19.57	$18,200.10	271,505
2/16/2023	Jeremy Bender	CEO	Sell	3,022	$19.57	$59,140.54	1,186,776
2/16/2023	Samuel C. Blackman	Insider	Sell	674	$19.57	$13,190.18	1,243,660
2/10/2023	Samuel C. Blackman	Insider	Sell	10,000	$20.07	$200,700.00	1,241,710
1/23/2023	Jeremy Bender	CEO	Sell	12,500	$22.00	$275,000.00	1,181,486
1/20/2023	Charles N York II	CFO	Sell	10,000	$22.75	$227,500.00	268,810
1/10/2023	Samuel C. Blackman	Insider	Sell	10,000	$22.86	$228,600.00	1,250,148
1/3/2023	Julie Papanek Grant	Director	Sell	25,000	$20.65	$516,250.00	380,000
12/21/2022	Jeremy Bender	CEO	Sell	12,500	$20.32	$254,000.00	1,192,424
12/20/2022	Charles N York II	CFO	Sell	10,000	$20.07	$200,700.00	276,497
12/8/2022	Julie Papanek Grant	Director	Sell	4,358	$22.08	$96,224.64	405,000
12/1/2022	Julie Papanek Grant	Director	Sell	5,000	$21.75	$108,750.00	414,358
12/1/2022	Samuel C. Blackman	Insider	Sell	10,000	$21.45	$214,500.00	1,260,148
11/21/2022	Charles N York II	CFO	Sell	10,000	$20.76	$207,600.00	286,497
11/21/2022	Jeremy Bender	CEO	Sell	12,500	$20.76	$259,500.00	1,204,924
11/16/2022	Charles N York II	CFO	Sell	430	$21.46	$9,227.80	296,497
11/16/2022	Jeremy Bender	CEO	Sell	1,513	$21.46	$32,468.98	1,217,424
11/16/2022	Samuel C. Blackman	Insider	Sell	377	$21.46	$8,090.42	1,270,148
11/1/2022	Charles N York II	CFO	Sell	10,000	$20.03	$200,300.00	294,401
11/1/2022	Jeremy Bender	CEO	Sell	12,500	$20.03	$250,375.00	1,215,375
11/1/2022	Julie Papanek Grant	Director	Sell	5,000	$20.04	$100,200.00	424,358
10/3/2022	Charles N York II	CFO	Sell	10,000	$20.05	$200,500.00	304,401
10/3/2022	Jeremy Bender	CEO	Sell	12,500	$20.05	$250,625.00	1,227,875
10/3/2022	Julie Papanek Grant	Director	Sell	5,000	$20.06	$100,300.00	434,358
9/21/2022	Julie Papanek Grant	Director	Sell	613,603	$18.55	$11,382,335.65	8,464,301
9/20/2022	Xi L.P. Canaan	Major Shareholder	Sell	148,670	$19.51	$2,900,551.70	9,077,904
9/19/2022	Julie Papanek Grant	Director	Sell	76,725	$20.57	$1,578,233.25	9,226,574
9/16/2022	Xi L.P. Canaan	Major Shareholder	Sell	115,307	$21.55	$2,484,865.85	9,303,299
9/15/2022	Julie Papanek Grant	Director	Sell	51,281	$22.85	$1,171,770.85	9,418,606
9/14/2022	Xi L.P. Canaan	Major Shareholder	Sell	106,111	$23.68	$2,512,708.48	9,469,887
9/13/2022	Julie Papanek Grant	Director	Sell	87,647	$24.40	$2,138,586.80	9,575,998
9/2/2022	Papanek Julie Grant	Director	Sell	5,000	$23.82	$119,100.00	439,358
8/16/2022	Charles N York II	CFO	Sell	1,089	$24.31	$26,473.59	324,401
8/16/2022	Jeremy Bender	CEO	Sell	4,003	$24.31	$97,312.93	1,252,875
8/16/2022	Samuel C. Blackman	Insider	Sell	941	$24.31	$22,875.71	1,299,338
8/4/2022	Charles N York II	CFO	Sell	10,000	$20.05	$200,500.00	321,365
8/4/2022	Jeremy Bender	CEO	Sell	12,500	$20.00	$250,000.00	1,246,192
8/4/2022	Papanek Julie Grant	Director	Sell	5,000	$20.00	$100,000.00	454,358
8/1/2022	Samuel C. Blackman	Insider	Sell	10,000	$16.88	$168,800.00	1,296,718
7/18/2022	Charles N York II	CFO	Sell	2,500	$20.00	$50,000.00	331,365
7/18/2022	Papanek Julie Grant	Director	Sell	2,600	$20.00	$52,000.00	459,358
7/8/2022	Charles N York II	CFO	Sell	1,416	$20.00	$28,320.00	333,865
7/8/2022	Jeremy Bender	CEO	Sell	1,795	$20.00	$35,900.00	1,261,292
7/8/2022	Papanek Julie Grant	Director	Sell	1,242	$20.00	$24,840.00	461,958
7/5/2022	Charles N York II	CFO	Sell	800	$20.00	$16,000.00	335,281
7/5/2022	Jeremy Bender	CEO	Sell	857	$20.00	$17,140.00	1,263,087
7/1/2022	Charles N York II	CFO	Sell	1,479	$20.00	$29,580.00	336,081
7/1/2022	Jeremy Bender	CEO	Sell	1,746	$20.00	$34,920.00	1,263,944
7/1/2022	Papanek Julie Grant	Director	Sell	1,000	$20.00	$20,000.00	464,000
7/1/2022	Samuel C. Blackman	Insider	Sell	10,000	$18.72	$187,200.00	1,306,718
6/17/2022	Ai Day1 Llc	Major Shareholder	Buy	1,200,000	$15.00	$18,000,000.00	10,684,638
6/17/2022	Michael Gladstone	Director	Buy	766,667	$15.00	$11,500,005.00	766,667
6/15/2022	Samuel C. Blackman	Insider	Sell	50,000	$16.26	$813,000.00	1,316,718
1/20/2022	Ai Day1 Llc	Major Shareholder	Buy	4,615	$14.73	$67,978.95
1/18/2022	Ai Day1 Llc	Major Shareholder	Buy	43,429	$14.26	$619,297.54
1/3/2022	Samuel C. Blackman	Insider	Sell	10,000	$17.10	$171,000.00
12/8/2021	Pharmaceutical Co Ltd Takeda	Major Shareholder	Sell	110,338	$18.03	$1,989,394.14
12/6/2021	Pharmaceutical Co Ltd Takeda	Major Shareholder	Sell	97,692	$18.05	$1,763,340.60
12/3/2021	Pharmaceutical Co Ltd Takeda	Major Shareholder	Sell	12,517	$18.47	$231,188.99
12/1/2021	Samuel C. Blackman	Insider	Sell	10,000	$17.22	$172,200.00

Election warning coming true…

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - watch it before it's too late.

Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for Day One Biopharmaceuticals (NASDAQ:DAWN)

87.95% of Day One Biopharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Day One Biopharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/14/2024	Maverick Capital Ltd.	2,114,006	$29.45M	0.6%	+74.5%	2.096%
11/14/2024	PFM Health Sciences LP	342,172	$4.77M	0.3%	-13.7%	0.339%
11/14/2024	Braidwell LP	4,873,853	$67.89M	1.9%	+60.5%	4.833%
11/14/2024	Verition Fund Management LLC	31,075	$0.43M	0.0%	+31.4%	0.031%
11/14/2024	Vestal Point Capital LP	2,500,000	$34.83M	2.6%	+100.0%	2.479%
11/14/2024	Walleye Capital LLC	34,266	$0.48M	0.0%	N/A	0.034%
11/14/2024	Martingale Asset Management L P	71,304	$0.99M	0.0%	+9.6%	0.071%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	65,193	$0.91M	0.0%	-6.5%	0.065%
11/14/2024	Stonepine Capital Management LLC	205,675	$2.87M	1.8%	N/A	0.204%
11/13/2024	FMR LLC	7,412,380	$103.25M	0.0%	+178.5%	7.350%
11/13/2024	Dynamic Technology Lab Private Ltd	12,474	$0.17M	0.0%	N/A	0.012%
11/12/2024	Algert Global LLC	71,487	$1M	0.0%	+248.8%	0.071%
11/12/2024	Charles Schwab Investment Management Inc.	507,448	$7.07M	0.0%	+14.6%	0.503%
11/9/2024	Intech Investment Management LLC	23,236	$0.32M	0.0%	N/A	0.023%
11/7/2024	First Turn Management LLC	947,878	$13.20M	2.1%	N/A	0.940%
11/7/2024	Quest Partners LLC	7,751	$0.11M	0.0%	+9,238.6%	0.008%
11/5/2024	GSA Capital Partners LLP	59,259	$0.83M	0.1%	N/A	0.059%
11/4/2024	TimesSquare Capital Management LLC	1,827,695	$25.46M	0.4%	+8.2%	1.812%
10/25/2024	SteelPeak Wealth LLC	17,400	$0.24M	0.0%	+9.8%	0.020%
10/25/2024	China Universal Asset Management Co. Ltd.	19,203	$0.27M	0.0%	+87.0%	0.022%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	3,611	$51K	0.0%	+38.4%	0.004%
10/23/2024	Hennion & Walsh Asset Management Inc.	63,566	$0.89M	0.0%	-1.2%	0.073%
10/10/2024	Essex Investment Management Co. LLC	184,230	$2.57M	0.4%	N/A	0.211%
10/10/2024	Exchange Traded Concepts LLC	12,286	$0.17M	0.0%	-19.8%	0.014%
10/5/2024	Handelsbanken Fonder AB	27,000	$0.38M	0.0%	+16.9%	0.031%
9/16/2024	Point72 DIFC Ltd	8,992	$0.12M	0.0%	N/A	0.010%
8/21/2024	Regency Capital Management Inc. DE	10,000	$0.14M	0.1%	-9.1%	0.011%
8/19/2024	Point72 Asset Management L.P.	470,247	$6.48M	0.0%	N/A	0.538%
8/16/2024	Algert Global LLC	20,497	$0.28M	0.0%	-18.1%	0.023%
8/16/2024	Driehaus Capital Management LLC	706,446	$9.74M	0.1%	-1.7%	0.808%
8/15/2024	The Manufacturers Life Insurance Company	48,274	$0.67M	0.0%	-4.2%	0.055%
8/15/2024	Maverick Capital Ltd.	1,211,138	$16.69M	0.3%	-3.6%	1.386%
8/15/2024	Deerfield Management Company L.P. Series C	2,923,137	$40.28M	0.7%	+65.6%	3.345%
8/15/2024	AQR Capital Management LLC	113,020	$1.56M	0.0%	+517.0%	0.129%
8/14/2024	Squarepoint Ops LLC	186,484	$2.57M	0.0%	N/A	0.213%
8/14/2024	Point72 DIFC Ltd	8,992	$0.12M	0.0%	N/A	0.010%
8/14/2024	Marshall Wace LLP	161,129	$2.22M	0.0%	+20.1%	0.184%
8/14/2024	Ally Bridge Group NY LLC	536,095	$7.39M	4.4%	N/A	0.613%
8/14/2024	ProShare Advisors LLC	13,787	$0.19M	0.0%	-20.7%	0.016%
8/14/2024	Profund Advisors LLC	27,607	$0.38M	0.0%	-9.8%	0.032%
8/12/2024	Hsbc Holdings PLC	11,658	$0.16M	0.0%	N/A	0.013%
8/9/2024	Renaissance Technologies LLC	72,140	$0.99M	0.0%	N/A	0.083%
8/9/2024	Dimensional Fund Advisors LP	888,117	$12.24M	0.0%	-9.5%	1.016%
8/1/2024	Rhumbline Advisers	85,438	$1.18M	0.0%	-4.8%	0.098%
7/26/2024	Bank of New York Mellon Corp	208,396	$2.87M	0.0%	-3.2%	0.238%
7/20/2024	Hennion & Walsh Asset Management Inc.	64,359	$0.89M	0.0%	+8.6%	0.074%
7/17/2024	SteelPeak Wealth LLC	15,850	$0.22M	0.0%	N/A	0.018%
7/12/2024	SG Americas Securities LLC	8,222	$0.11M	0.0%	N/A	0.009%
5/16/2024	California State Teachers Retirement System	49,340	$0.82M	0.0%	-6.8%	0.056%
5/16/2024	Janus Henderson Group PLC	2,032,384	$33.58M	0.0%	+19.8%	2.326%
5/16/2024	Bayesian Capital Management LP	13,374	$0.22M	0.0%	N/A	0.015%
5/15/2024	Estuary Capital Management LP	1,611,137	$26.62M	10.8%	+82.5%	1.844%
5/15/2024	Price T Rowe Associates Inc. MD	2,299,764	$37.99M	0.0%	-0.7%	2.632%
5/15/2024	Altitude Crest Partners Inc.	195,497	$3.23M	1.4%	N/A	0.224%
5/10/2024	Vanguard Group Inc.	4,774,483	$78.87M	0.0%	+0.1%	5.464%
5/9/2024	State Board of Administration of Florida Retirement System	10,650	$0.18M	0.0%	-40.4%	0.012%
5/8/2024	Summit Rock Advisors LP	51,502	$0.85M	0.3%	N/A	0.059%
5/8/2024	ProShare Advisors LLC	17,379	$0.29M	0.0%	+9.1%	0.020%
5/7/2024	Regency Capital Management Inc. DE	11,000	$0.18M	0.1%	-8.3%	0.013%
5/7/2024	TimesSquare Capital Management LLC	1,635,145	$27.01M	0.4%	-1.9%	1.871%
5/6/2024	Atlas Venture Life Science Advisors LLC	6,430,257	$106.23M	9.8%	-15.5%	7.359%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	21,863	$0.36M	0.0%	-50.4%	0.025%
4/29/2024	China Universal Asset Management Co. Ltd.	16,817	$0.28M	0.0%	+67.1%	0.019%
4/17/2024	Hennion & Walsh Asset Management Inc.	59,289	$0.98M	0.1%	+2.5%	0.068%
3/5/2024	Fisher Asset Management LLC	68,446	$1M	0.0%	+89.0%	0.078%
3/5/2024	Wellington Management Group LLP	208,969	$3.05M	0.0%	+77.7%	0.239%
3/1/2024	Goldman Sachs Group Inc.	2,118,849	$30.94M	0.0%	+28.7%	2.425%
2/29/2024	Quintet Private Bank Europe S.A.	3,313	$48K	0.0%	+43.2%	0.004%
2/20/2024	Quarry LP	5,000	$73K	0.0%	-23.3%	0.006%
2/15/2024	PFM Health Sciences LP	1,303,575	$19.03M	1.1%	-41.4%	1.498%
2/15/2024	Parkman Healthcare Partners LLC	625,749	$9.14M	1.3%	+34.2%	0.719%
2/14/2024	Braidwell LP	4,215,573	$61.55M	2.3%	+13.5%	4.843%
2/14/2024	Superstring Capital Management LP	379,626	$5.54M	4.0%	N/A	0.436%
2/13/2024	Rafferty Asset Management LLC	236,347	$3.45M	0.0%	-0.3%	0.272%
2/13/2024	NEOS Investment Management LLC	15,507	$0.23M	0.0%	N/A	0.018%
2/9/2024	Franklin Resources Inc.	4,236,795	$61.86M	0.0%	+4.2%	4.868%
2/9/2024	Quest Partners LLC	1,980	$29K	0.0%	N/A	0.002%
2/9/2024	Dynamic Technology Lab Private Ltd	10,651	$0.16M	0.0%	N/A	0.012%
2/8/2024	Nicholas Investment Partners LP	303,318	$4.43M	0.5%	-86.1%	0.348%
2/8/2024	First Turn Management LLC	1,700,949	$24.83M	3.6%	N/A	1.954%
2/7/2024	Teacher Retirement System of Texas	10,860	$0.16M	0.0%	-15.7%	0.012%
2/7/2024	TimesSquare Capital Management LLC	1,666,065	$24.33M	0.4%	+45.8%	1.914%
2/6/2024	Charles Schwab Investment Management Inc.	452,934	$6.61M	0.0%	+1.3%	0.520%
2/6/2024	Fisher Asset Management LLC	68,411	$1M	0.0%	+88.9%	0.079%
2/1/2024	New York State Common Retirement Fund	78,299	$1.14M	0.0%	+20.5%	0.090%
2/1/2024	Handelsbanken Fonder AB	17,400	$0.25M	0.0%	N/A	0.020%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	6,978	$0.10M	0.0%	-24.6%	0.008%
1/30/2024	Vontobel Holding Ltd.	15,500	$0.23M	0.0%	-34.9%	0.018%
1/24/2024	Arizona State Retirement System	13,373	$0.20M	0.0%	+8.2%	0.015%
1/24/2024	China Universal Asset Management Co. Ltd.	10,067	$0.15M	0.0%	+352.2%	0.012%
1/16/2024	Legato Capital Management LLC	41,918	$0.61M	0.1%	+14.3%	0.048%
1/12/2024	SG Americas Securities LLC	64,692	$0.95M	0.0%	+74.9%	0.074%
1/5/2024	Exchange Traded Concepts LLC	10,072	$0.15M	0.0%	+34.0%	0.012%
12/18/2023	Vanguard Group Inc.	4,629,754	$56.81M	0.0%	+8.1%	5.319%
12/1/2023	Wellington Management Group LLP	117,576	$1.44M	0.0%	+5.0%	0.135%
11/22/2023	Polar Capital Holdings Plc	1,935,000	$23.74M	0.2%	+9.0%	2.223%
11/21/2023	Walleye Capital LLC	277,206	$3.40M	0.0%	N/A	0.318%
11/17/2023	TimesSquare Capital Management LLC	1,142,610	$14.02M	0.2%	+41.8%	1.313%
11/15/2023	Adage Capital Partners GP L.L.C.	1,036,599	$12.72M	0.0%	-57.6%	1.191%
11/15/2023	Alps Advisors Inc.	64,153	$0.79M	0.0%	+2.5%	0.074%

Data available starting January 2016

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.

Today's Range

Now: $14.32

$14.27

$15.05

50 Day Range

MA: $14.44

$13.53

$16.39

52 Week Range

Now: $14.32

$11.30

$18.07

Volume

859,445 shs

Average Volume

955,020 shs

Market Capitalization

$1.44 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Day One Biopharmaceuticals?: Day One Biopharmaceuticals' top insider investors include:
Ai Day1 Llc (Major Shareholder)
Samuel C Blackman (Insider)
Jeremy Bender (CEO)
Julie Papanek Grant (Director)
Charles N York II (CFO)
Saira Ramasastry (Director)
Adam Dubow (General Counsel)
Learn More about top insider investors at Day One Biopharmaceuticals.
Who are the major institutional investors of Day One Biopharmaceuticals?: Day One Biopharmaceuticals' top institutional shareholders include:
FMR LLC — 7.35%
Braidwell LP — 4.83%
Vestal Point Capital LP — 2.48%
Maverick Capital Ltd. — 2.10%
TimesSquare Capital Management LLC — 1.81%
First Turn Management LLC — 0.94%
Learn More about top institutional investors of Day One Biopharmaceuticals stock.
Which major investors are selling Day One Biopharmaceuticals stock?: During the previous quarter, DAWN stock was sold by these institutional investors:
PFM Health Sciences LP
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Exchange Traded Concepts LLC
Hennion & Walsh Asset Management Inc.
During the previous year, company insiders that have sold Day One Biopharmaceuticals company stock include:
Ai Day1 Llc (Major Shareholder)
Samuel C Blackman (Insider)
Jeremy Bender (CEO)
Julie Papanek Grant (Director)
Charles N York II (CFO)
Learn More investors selling Day One Biopharmaceuticals stock.
Which major investors are buying Day One Biopharmaceuticals stock?: Within the previous quarter, DAWN stock was acquired by institutional investors including:
FMR LLC
Braidwell LP
Vestal Point Capital LP
First Turn Management LLC
Maverick Capital Ltd.
Stonepine Capital Management LLC
Essex Investment Management Co. LLC
TimesSquare Capital Management LLC